These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 6206315
1. Electrophysiological studies of indecainide hydrochloride, a new antiarrhythmic agent, in canine cardiac tissues. Steinberg MI, Wiest SA. J Cardiovasc Pharmacol; 1984; 6(4):614-21. PubMed ID: 6206315 [Abstract] [Full Text] [Related]
2. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues. Pankucsi C, Bányász T, Magyar J, Gyönös I, Kovács A, Varró A, Szénási G, Nánási PP. Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672 [Abstract] [Full Text] [Related]
3. Effects on rabbit cardiac potentials of aprindine and indecainide, a new antiarrhythmic agent, in normoxia and hypoxia. Dennis PD, Vaughan Williams EM. Br J Pharmacol; 1985 May; 85(1):11-9. PubMed ID: 4027460 [Abstract] [Full Text] [Related]
4. Electrophysiologic effects of McN-4130, a new antiarrhythmic compound, on isolated cardiac tissue. Damiano BP, Brannan MD. J Cardiovasc Pharmacol; 1987 Nov; 10(5):498-508. PubMed ID: 2447397 [Abstract] [Full Text] [Related]
5. Barucainide, a novel class Ib antiarrhythmic agent with a slow kinetic property: electrophysiologic observations in isolated canine and rabbit cardiac muscle. Takanaka C, Singh BN. Am Heart J; 1990 May; 119(5):1050-60. PubMed ID: 2330863 [Abstract] [Full Text] [Related]
6. Electrophysiological properties of a new antiarrhythmic agent, bisaramil on guinea-pig, rabbit and canine cardiac preparations. Sunami A, Sawanobori T, Adaniya H, Hiraoka M. Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):323-30. PubMed ID: 1961258 [Abstract] [Full Text] [Related]
7. Electrophysiological effects of CI-980, a tubulin binding agent, on guinea-pig papillary muscles. Pérez O, Valenzuela C, Delpón E, Tamargo J. Br J Pharmacol; 1997 Jan; 120(2):187-92. PubMed ID: 9117108 [Abstract] [Full Text] [Related]
8. Electrophysiological effects of OPC-88117, a new antiarrhythmic agent on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts. Toyama J, Kodama I, Honjo H, Kamiya K. Br J Pharmacol; 1989 Sep; 98(1):177-85. PubMed ID: 2553186 [Abstract] [Full Text] [Related]
9. Electrophysiological effects of SD-3212, a new antiarrhythmic agent with vasodilator action, on guinea-pig ventricular cells. Kodama I, Suzuki R, Maruyama K, Toyama J. Br J Pharmacol; 1995 Jan; 114(2):503-9. PubMed ID: 7881749 [Abstract] [Full Text] [Related]
10. Voltage- and rate-dependent depression of Vmax of action potentials by a new antiarrhythmic agent, E-0747, in swine cardiac Purkinje fibers. Sawada K, Shoji T, Igarashi T, Hiraoka M. J Cardiovasc Pharmacol; 1987 Jan; 9(1):51-6. PubMed ID: 2434794 [Abstract] [Full Text] [Related]
11. Membrane potential-dependent effects of SC-36602, a new class I antiarrhythmic agent on cardiac action potentials. Borowicz LE, Schniepp HC, Sanguinetti MC. J Cardiovasc Pharmacol; 1987 Jan; 9(1):57-64. PubMed ID: 2434795 [Abstract] [Full Text] [Related]
12. Electrophysiological effects of E-3753, a new antiarrhythmic drug, in guinea-pig ventricular muscle. Delpón E, Valenzuela C, Tamargo J. Br J Pharmacol; 1989 Apr; 96(4):970-6. PubMed ID: 2743087 [Abstract] [Full Text] [Related]
13. Class I and III antiarrhythmic actions of prazosin in guinea-pig papillary muscles. Pérez O, Valenzuela C, Delpón E, Tamargo J. Br J Pharmacol; 1994 Mar; 111(3):717-22. PubMed ID: 8019750 [Abstract] [Full Text] [Related]
14. Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations. Pérez O, Gay P, Franqueza L, Carrón R, Valenzuela C, Delpón E, Tamargo J. Br J Pharmacol; 1995 Jul; 115(5):787-94. PubMed ID: 8548178 [Abstract] [Full Text] [Related]
15. Electrophysiological studies of penticainide (CM 7857), a new antiarrhythmic agent, in mammalian myocardium. Gautier P, Guiraudou P, Pezziardi F, Bertrand JP, Gagnol JP. J Cardiovasc Pharmacol; 1987 May; 9(5):601-10. PubMed ID: 2439843 [Abstract] [Full Text] [Related]
16. Effects of AFD-21, a new class I antiarrhythmic agent, and AFD-19, its active metabolite, on the maximal rate of rise of action potentials in guinea pig papillary muscles: dependence on time, voltage, and action potential duration. Kojima M, Ban T. J Cardiovasc Pharmacol; 1989 Mar; 13(3):483-93. PubMed ID: 2471896 [Abstract] [Full Text] [Related]
17. Investigation of electrophysiologic mechanisms for the antiarrhythmic actions of R 56865 in cardiac glycoside toxicity. Damiano BP, Stump GL, Yagel SK. J Cardiovasc Pharmacol; 1991 Sep; 18(3):415-28. PubMed ID: 1720842 [Abstract] [Full Text] [Related]
18. Electrophysiological effects of AFD-21 and AFD-19, new antiarrhythmic compounds on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts. Kodama I, Kamiya K, Kawamura T, Suzuki R, Toyama J. Br J Pharmacol; 1990 Dec; 101(4):803-8. PubMed ID: 2085705 [Abstract] [Full Text] [Related]
19. Evaluation and interpretation of voltage- and frequency-dependent electrophysiologic effects of a new class I antiarrhythmic agent (nicainoprol) on guinea pig papillary muscle and isolated heart. Weirich J, Antoni H. J Cardiovasc Pharmacol; 1988 Dec; 12(6):664-71. PubMed ID: 2467084 [Abstract] [Full Text] [Related]
20. Electrophysiological actions of BRB-I-28 in canine myocardial tissues. Patterson E, Scherlag BJ, Berlin KD, Lazzara R. J Pharmacol Exp Ther; 1991 Nov; 259(2):558-65. PubMed ID: 1941607 [Abstract] [Full Text] [Related] Page: [Next] [New Search]